AI Terminal

MODULE: AI_ANALYST
Interactive Q&A, Risk Assessment, Summarization
MODULE: DATA_EXTRACT
Excel Export, XBRL Parsing, Table Digitization
MODULE: PEER_COMP
Sector Benchmarking, Sentiment Analysis
SYSTEM ACCESS LOCKED
Authenticate / Register Log In

Assura PLC

Report Publication Announcement May 11, 2020

4924_rns_2020-05-11_0a3e6b84-2b4a-4a38-82e1-31a013ea8e3a.html

Report Publication Announcement

Open in Viewer

Opens in native device viewer

National Storage Mechanism | Additional information

RNS Number : 3386M

Assura PLC

11 May 2020

11 May 2020

Assura plc

Confirmation of announcement date for results

Assura plc ("Assura"), the leading primary care property investor and developer, will announce its annual results for the financial year ended 31 March 2020 on Thursday, 21 May 2020.

A presentation followed by Q&A with Jonathan Murphy and Jayne Cottam will be streamed at the link below at 10.00am BST.

Webcast link: https://webcasting.brrmedia.co.uk/broadcast/5eafe78331da814c9fc6d528 

ENDS

For further information, please contact:

Assura plc:

Jayne Cottam, CFO

David Purcell, Head of Financial Reporting
Tel: 01925 420 680

Email: [email protected]
Finsbury:

Gordon Simpson

James Thompson
Tel: 0207 251 3801

Email: [email protected]

Notes to Editors

Assura plc, a constituent of the FTSE 250 and the EPRA* indices, is a UK REIT and long-term investor in and developer of primary care property. The company, headquartered in Warrington, works with GPs, health professionals and the NHS to create outstanding spaces for health services in our communities. At 30 September 2019, Assura's property portfolio was valued at £2,039 million.

Further information is available at www.assuraplc.com

*EPRA is a registered trademark of the European Public Real Estate Association.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.

END

NORQDLFBBELLBBE

Talk to a Data Expert

Have a question? We'll get back to you promptly.